MR [Mindray Medical International] 6-K: (Original Filing)
[Shenzhen, China – November 3, 2014 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2014. Highlights for Third Quarter 2014 - Net revenues increased 9.6% year-over-year to $324.6 million. China sales grew 17.9% year-over-year, representing 48.0% of] []